Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of SLC29A1 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human,Mouse |
| Host species | Rabbit |
| Applications | WB-Tr |
More info about SLC29A1 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB2255 |
| Product name: | SLC29A1 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of SLC29A1. |
| Gene id: | 2030 |
| Gene name: | SLC29A1 |
| Gene alias: | ENT1|MGC1465|MGC3778 |
| Gene description: | solute carrier family 29 (nucleoside transporters), member 1 |
| Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to internal region of human SLC29A1. |
| Protein accession: | NP_004946;Q99808 |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:1000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human,Mouse |
| Application image: |  |
| Application image note: | Western blot analysis of ENT1 (SLC29A1) (arrow) using rabbit SLC29A1 polyclonal antibody (Cat # PAB2255). 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected with the ENT1 (SLC29A1) gene (Lane 2) (Origene Technologies). |
| Applications: | WB-Tr |
| Shipping condition: | Dry Ice |
| Publications: | Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy.Sasaki H, Murakami Y, Uemura K, Sudo T, Hashimoto Y, Kondo N, Sueda T. Br J Cancer. 2014 Sep 23;111(7):1275-84. |